Ngā hua rapu - T Alnadaf

  • E whakaatu ana i te 1 - 3 hua o te 3
Whakamahine hua
  1. 1
    Combination of mutations in human immunodeficiency virus type 1 reverse transcriptase required for resistance to the carbocyclic nucleoside 1592U89.

    Combination of mutations in human immunodeficiency virus type 1 reverse transcriptase required for resistance to the carbocyclic nucleoside 1592U89. mā Tisdale, M, Alnadaf, T, Cousens, D

    I whakaputaina 1997
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Combination of mutations in human immunodeficiency virus type 1 reverse transcriptase required for resistance to the carbocyclic nucleoside 1592U89

    Combination of mutations in human immunodeficiency virus type 1 reverse transcriptase required for resistance to the carbocyclic nucleoside 1592U89 mā Margaret Tisdale, T Alnadaf, Diane J. Cousens

    I whakaputaina 1997
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Identification and characterization of a novel human vanilloid receptor-like protein, VRL-2

    Identification and characterization of a novel human vanilloid receptor-like protein, VRL-2 mā Natalie S. Delany, Michael Hurle, P. Facer, Tanja Alnadaf, Christopher Plumpton, Ian J. Kinghorn, Chee Gee See, Michael Costigan, Praveen Anand, Clifford J. Woolf, Daniel Crowther, Philippe Sanséau, Simon Tate

    I whakaputaina 2001
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: